Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas

被引:192
作者
Kowalczuk, A
Macdonald, RL
Amidei, C
Dohrmann, G
Erickson, RK
Hekmatpanah, J
Krauss, S
Krishnasamy, S
Masters, G
Mullan, SF
Mundt, AJ
Sweeney, P
Vokes, EE
Weir, BKA
Wollman, RL
机构
[1] UNIV CHICAGO, MED CTR, NEUROSURG SECT, DEPT SURG, CHICAGO, IL 60637 USA
[2] UNIV CHICAGO, MED CTR, DEPT RADIAT & CELLULAR ONCOL, CHICAGO, IL 60637 USA
[3] UNIV CHICAGO, MED CTR, DEPT MED, HEMATOL ONCOL SECT, CHICAGO, IL 60637 USA
关键词
brain neoplasm; cytoreductive surgery; malignant glioma; outcome; prognostic factor; radiation therapy;
D O I
10.1097/00006123-199711000-00004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE: This study used quantitative radiological imaging to determine the effect of surgical resection on postoperative survival of patients with malignant astrocytomas. Previous studies relied on the surgeons' impressions of the amount of tumor removed, which is a less reliable measure of the extent of resection. METHODS: Information concerning possible prognostic factors was collected for 75 patients under going magnetic resonance imaging or computed tomography preoperatively and within 10 days postoperatively, Image analysis of the neuroradiological studies was conducted to quantify pre-and postoperative total tumor volumes and enhancing volumes. Univariate and multivariate proportional hazards models were used to analyze the regression of survival regarding 22 covariates that might affect survival. The covariates that were entered included age, gender, tumor grade, cumulative radiation dose, chemotherapy, seizures as a first symptom, Karnofsky performance status at presentation, pre-and postoperative total and enhancing tumor volumes, ratio of pre-to postoperative total and enhancing tumor volumes, tumor location, surgeon's impression of the degree of resection, and subsequent surgery. RESULTS: There were 23 patients with anaplastic astrocytomas and 52 with glioblastomas multiforme. The estimated mean survival time was 27 months for patients undergoing gross total resection, 33 months for subtotal resection, and 13 months for open or stereotactic biopsy. Five factors that were significant predictors of survival in multivariate analysis were tumor grade, age, Karnofsky performance status, radiation dose, and postoperative complications (P < 0.05). In univariate analysis, tumor grade, radiation dose, age, Karnofsky status, complications, presence of enhancing tumor in postoperative imaging, and postoperative volume of enhancing tumor were significantly associated with survival (P < 0.05). CONCLUSION: We conclude that the most important prognostic factors affecting survival of patients with anaplastic astrocytomas and glioblastomas multiforme are tumor grade, age, preoperative performance status, and radiation therapy. Postoperative complications adversely affect survival. Aggressive surgical resection did not impart a significant increase in survival time. Surgical resection may improve survival, but its importance is less than that of other factors and may be demonstrable only by larger studies.
引用
收藏
页码:1028 / 1036
页数:9
相关论文
共 66 条
  • [51] MULTIMODALITY MANAGEMENT OF RECURRENT ADULT MALIGNANT GLIOMAS - RESULTS OF A PHASE-II MULTIAGENT CHEMOTHERAPY STUDY AND ANALYSIS OF CYTOREDUCTIVE SURGERY
    ROSTOMILY, RC
    SPENCE, AM
    DUONG, D
    MCCORMICK, K
    BLAND, M
    BERGER, MS
    [J]. NEUROSURGERY, 1994, 35 (03) : 378 - 388
  • [52] SANDBERGWOLLHEIM M, 1991, CANCER, V68, P22, DOI 10.1002/1097-0142(19910701)68:1<22::AID-CNCR2820680105>3.0.CO
  • [53] 2-2
  • [54] RADIOSURGERY IN THE INITIAL MANAGEMENT OF MALIGNANT GLIOMAS - SURVIVAL COMPARISON WITH THE RTOG RECURSIVE PARTITIONING ANALYSIS
    SARKARIA, JN
    MEHTA, MP
    LOEFFLER, JS
    BUATTI, JM
    CHAPPELL, RJ
    LEVIN, AB
    ALEXANDER, E
    FRIEDMAN, WA
    KINSELLA, TJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (04): : 931 - 941
  • [55] SCHARFEN CO, 1992, INT J RADIAT ONCOL, V24, P583
  • [56] RANDOMIZED TRIAL OF 3 CHEMOTHERAPY REGIMENS AND 2 RADIOTHERAPY REGIMENS IN POSTOPERATIVE TREATMENT OF MALIGNANT GLIOMA - BRAIN-TUMOR COOPERATIVE GROUP TRIAL-8001
    SHAPIRO, WR
    GREEN, SB
    BURGER, PC
    MAHALEY, MS
    SELKER, RG
    VANGILDER, JC
    ROBERTSON, JT
    RANSOHOFF, J
    MEALEY, J
    STRIKE, TA
    PISTENMAA, DA
    [J]. JOURNAL OF NEUROSURGERY, 1989, 71 (01) : 1 - 9
  • [57] INFLUENCE OF LOCATION AND EXTENT OF SURGICAL RESECTION ON SURVIVAL OF PATIENTS WITH GLIOBLASTOMA-MULTIFORME - RESULTS OF 3 CONSECUTIVE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) CLINICAL-TRIALS
    SIMPSON, JR
    HORTON, J
    SCOTT, C
    CURRAN, WJ
    RUBIN, P
    FISCHBACH, J
    ISAACSON, S
    ROTMAN, M
    ASBELL, SO
    NELSON, JS
    WEINSTEIN, AS
    NELSON, DF
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (02): : 239 - 244
  • [58] LARGE EFFECT OF AGE ON THE SURVIVAL OF PATIENTS WITH GLIOBLASTOMA TREATED WITH RADIOTHERAPY AND BRACHYTHERAPY ROOST
    SNEED, PK
    PRADOS, MD
    MCDERMOTT, MW
    LARSON, DA
    MALEC, MK
    LAMBORN, KR
    DAVIS, RL
    WEAVER, KA
    WARA, WM
    PHILLIPS, TL
    GUTIN, PH
    [J]. NEUROSURGERY, 1995, 36 (05) : 898 - 903
  • [59] SNEED PK, 1994, SEMIN ONCOL, V21, P186
  • [60] SOFIETTI R, 1991, NEURO-ONCOLOGY, P179